Saturday, February 02, 2008

Partnership for Prescription Assistance

Dear Healthcare Provider:
The Partnership for Prescription Assistance (PPA), sponsored by America’s pharmaceutical research companies, is a central clearinghouse that connects individuals who are uninsured or lack adequate healthcare coverage to programs that provide prescription medicines for free or nearly free. The PPA is the largest private-sector patient assistance effort helping people in need who qualify obtain their medicines through more than 475 public and private patient assistance programs, including 180 programs offered by pharmaceutical companies. Since its launch in April 2005, the PPA has helped more than 4.3 million individuals find programs, but many more could benefit if they were only aware that help was available.
“The PPA is continuing to make tremendous inroads by assisting struggling Americans who need it most,” said Billy Tauzin, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA). “America’s pharmaceutical research companies are devoted to not only inventing medicines that allow patients to live longer, healthier, and more productive lives, but to making sure all patients have access to those medicines. That is why we continue to work with healthcare providers to make sure no patient goes without the medicines they need.”
Healthcare providers can direct their patients to the PPA’s easy-to-use Web site (www.pparx.org) or the toll-free number (1-888-4PPA-NOW) where trained operators field calls in more than 150 languages.
In addition, the PPA provides information on nearly 10,000 free healthcare clinics and has connected more than 194,000 patients with clinics and healthcare providers in their communities.
More than 1,300 national, state and local organizations, including the American Academy of Family Physicians, American College of Emergency Physicians, American Association of Clinical Endocrinologists, United Way of America, the YMCA and the National Alliance for Hispanic Health, have partnered with America’s pharmaceutical research companies to help spread the word about the PPA.